In Conversation with Steven Tong and Joshua Davis on adaptive platform trials

Anna Odone, Jesus Rodriguez-Manzano, and Alex Howard on artificial intelligence and infectious diseases

Catherine Liu and Joshua Hill on prevention and management of infections in people who are immunocompromised

Lilian Tina Minja and Norbert Heinrich on TB drug development

Leonardo Basso and Juan Pablo Torres on the NIRSE-CL study of nirsevimab in Chile

Jan Felix Drexler and Fernando Bozza on Oropouche virus

Prasad Kulkarni on dengue monoclonal antibodies

Oriol Mitjà on treatment of early syphilis in adults

Sofia Viegas and Stefan Niemann on emerging bedaquiline resistance in Mozambique

Luciano Moreira and Henrik Salje on Wolbachia control of mosquito-borne infections

Richard Maude on malaria chemoprophylaxis in Cambodia

Ben Cowling on COVID-19 vaccines in Hong Kong

Hugh Adler on monkeypox in the UK

Beate Kampmann, Karen Keddy, and Peter Ghazal on applying big data to childhood infectious diseases in LMICs

Laura Cooper and Sam Okiror on polio eradication in Africa

Paul Chapman on a hookworm vaccine

Josep Llibre on preventing SARS-CoV-2 transmission at concerts

Yap Boum on COVID-19 testing in low resource settings

Antimalarial resistance in southeast Asia

Trial in phage therapy for burn infections